Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Tesi, officially known as Suomen Teollisuussijoitus Oy, is a Finnish state-owned venture capital company established to foster economic growth and renewal in Finland. Founded with the mission to support promising Finnish companies, Tesi plays a pivotal role in the local startup ecosystem by providing essential funding and resources. The firm operates primarily within Europe, focusing on sectors that exhibit significant potential for global scalability. Tesi's investment strategy is notably balanced, with half of its capital allocated to direct investments in startups and scale-ups, while the other half is directed towards venture capital funds. This dual approach allows Tesi to leverage a diverse range of opportunities and support a broad spectrum of innovative companies.
Although specific quantitative metrics such as fund size or assets under management (AUM) are not disclosed, Tesi is recognized for its commitment to strengthening domestic ownership and enhancing the growth trajectory of Finnish enterprises. The firm is actively involved in various stages of investment, including seed, Series A, and growth equity, ensuring that it can support companies at different phases of their development. Tesi's reputation as a reliable partner in the Finnish venture capital landscape is underscored by its strategic focus on sectors such as deep technology, health technology, clean transition, and defense, which are critical for the future of the Finnish economy.
Tesi's investment focus is characterized by its commitment to supporting companies with genuine potential for global scalable growth. The firm invests in both venture capital funds and directly in startups, scale-ups, and industrial companies, ensuring a balanced approach to its investment strategy. Tesi targets sectors that are poised for significant advancements and market opportunities, including frontier technology, healthcare, climate solutions, and defense. This strategic focus allows Tesi to align its investments with emerging trends and technologies that are shaping the future.
In terms of investment stages, Tesi is active in seed, Series A, and growth equity, providing flexibility in its funding approach. The firm seeks to partner with founders and companies that demonstrate innovative solutions and a clear vision for growth. Tesi's investment philosophy emphasizes market-driven strategies, aiming for half of its investments to be direct and the other half to be through venture capital funds. This approach not only diversifies Tesi's portfolio but also enhances its ability to support a wide range of innovative companies across various sectors.
Tesi boasts a diverse and impressive portfolio of notable companies that exemplify its investment strategy and focus areas. Among its key investments are **Avenue Biosciences**, which accelerates the development of protein-based drugs using artificial intelligence, and **UpCloud**, a company dedicated to enhancing resilience in Europe’s digital infrastructure. Another significant investment is **Steady Energy**, which is pioneering small nuclear power solutions for district heating, showcasing Tesi's commitment to innovative energy solutions.
Additionally, Tesi has invested in **Onego Bio**, a company that produces egg protein without the use of chickens, reflecting its interest in sustainable food technologies. **IQM**, a leader in quantum computing, and **Sisu Auto**, a prominent player in the defense industry, further illustrate Tesi's focus on cutting-edge technology and critical sectors. Other notable portfolio companies include **Antler**, a platform supporting Nordic startups, and **Unikie**, which specializes in Finnish software expertise for global markets. This diverse portfolio not only highlights Tesi's strategic investment choices but also its role in fostering innovation across various high-growth sectors.
To pitch Tesi, founders should visit their website at tesi.fi or email info@tesi.fi. Tesi welcomes pitches that include detailed information about the business model, market potential, and growth strategy. They are open to both warm introductions and cold applications, making it accessible for various founders.
Tesi invests in seed, Series A, and growth equity stages, providing funding to companies at various phases of their development. This flexibility allows Tesi to support startups and scale-ups as they grow and evolve.
Founders can pitch Tesi by visiting their official website at tesi.fi or by sending an email to info@tesi.fi. It is advisable to prepare a comprehensive pitch that outlines the business model, market potential, and growth strategy.
Tesi focuses on several key sectors, including frontier technology, healthcare, climate solutions, and defense. The firm seeks to invest in companies that demonstrate potential for global scalable growth within these areas.
While specific check sizes are not disclosed, Tesi's investment strategy encompasses a range of funding amounts suitable for seed, Series A, and growth equity stages. This allows them to tailor their investments to the needs of the companies they support.
Tesi primarily invests within Europe, with a strong emphasis on supporting Finnish companies. The firm aims to strengthen domestic ownership and promote economic growth in Finland.
The application process for Tesi involves submitting a pitch through their website or via email. Founders should ensure that their pitch includes detailed information about their business and its growth potential.
Tesi provides strategic support to its portfolio companies, leveraging its network and resources to help them scale and succeed in their respective markets. This includes guidance on growth strategies and access to additional funding opportunities.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.